Bioceramics Market Expands with Rising Orthopedic Implant Adoption

The global bioceramics market was valued at USD 7.67 billion in 2023 and is anticipated to expand to USD 12.33 billion by 2030, registering a CAGR of 7.0% from 2024 to 2030. Market growth is primarily driven by the increasing prevalence of musculoskeletal disorders such as osteoporosis, osteoarthritis, and rheumatoid arthritis, particularly among the growing elderly population. The rising demand for advanced biomaterials that offer biocompatibility, durability, and reduced post-operative complications is further supporting market expansion.

Key Market Trends & Insights

North America dominated the bioceramics market in 2023, accounting for a 42.2% revenue share, supported by advanced healthcare infrastructure, high adoption of orthopedic and dental implants, and a strong presence of key manufacturers. Europe followed with a 34.2% share in 2023, driven largely by an aging population and increasing demand for joint replacement and dental procedures across the region.

From a material perspective, alumina-based bioceramics emerged as the leading segment, capturing 63.2% of the total market share in 2023. This dominance is attributed to their superior mechanical strength, wear resistance, and chemical stability. In terms of application, the dental segment held the largest share in 2023, supported by rising dental disorders, cosmetic dentistry demand, and increased utilization of bioceramic materials in crowns, bridges, and implants.

Market Size & Forecast

• 2023 Market Size: USD 7.67 Billion
• 2030 Projected Market Size: USD 12.33 Billion
• CAGR (2024–2030): 7.0%
• Largest Regional Market (2023): North America

Bioceramics are widely recognized for their biocompatibility, enabling seamless integration with human tissue while reducing the risk of post-surgical infections. These materials are extensively used in orthopedic load-bearing coatings, dental implants, bone graft substitutes, and bone cement, making them critical components in modern medical procedures.

Technological advancements in healthcare have resulted in a growing number of spinal and orthopedic surgeries worldwide. Bioceramics play a vital role in spinal fusion procedures, joint replacements, and bone grafting applications. Additionally, their use in both hard tissue and soft tissue repair has increased significantly, particularly for aging populations and trauma-related injuries. Continuous innovation in tissue engineering and regenerative medicine is expected to further enhance the adoption of bioceramics during the forecast period.

Changing dietary habits and nutritional deficiencies have contributed to worsening dental health, including higher incidences of cavities and tooth deterioration. As a result, dental treatments such as fillings, restorations, and cosmetic procedures have increased, driving demand for bioceramics in dental care applications, including crowns, bridges, and implant components.

Despite favorable growth prospects, the market faces notable challenges. Ensuring long-term durability and consistent performance of bioceramic implants throughout a patient’s lifetime remains critical to minimizing implant failures and revision surgeries. Additionally, the relatively high cost of bioceramic implants—encompassing manufacturing, raw materials, and associated healthcare expenses—poses affordability concerns compared to alternative biomaterials. Manufacturers must balance quality, performance, and cost-effectiveness while meeting stringent regulatory standards.

Order a free sample PDF of the Bioceramics Market Intelligence Study, published by Grand View Research.

Key Bioceramics Company Insights

The global bioceramics market is relatively consolidated, with major players such as Amedica Corporation, Tosoh Corporation, CoorsTek, and others focusing on both organic and inorganic growth strategies. These include continuous investments in research and development to improve material durability, performance, and clinical outcomes.

• Zimmer Biomet Holdings, Inc., headquartered in the U.S., offers a broad portfolio of musculoskeletal health solutions, including orthopedic implants, trauma products, biologics, and dental implants. The company emphasizes innovation to support surgeons across multiple specialties.
• Straumann is a prominent player specializing in tissue regeneration, dental implants, prosthetics, and digital dentistry solutions. Its offerings include CAD/CAM prosthetics, intra-oral scanning, and computer-guided surgery, along with products focused on oral tissue regeneration and tooth preservation.

Key Bioceramics Companies

• Amedica Corporation
• Bonesupport AB
• Comp3
• Carborundum Universal Ltd.
• CoorsTek
• Jyoti Ceramic Industries Pvt. Ltd.
• Kyocera Corporation
• Morgan Advanced Types
• Nobel Biocare Holding AG
• Sagemax Bioceramics
• Tosoh Corporation
• Zimmer Biomet Holdings, Inc.

Conclusion

The bioceramics market is poised for steady growth through 2030, supported by rising orthopedic and dental procedures, an aging global population, and continuous advancements in medical technology. While cost and durability challenges persist, ongoing innovation and expanding clinical applications are expected to strengthen market adoption, positioning bioceramics as a critical material segment within modern healthcare solutions.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.